Recent studies have shown that PTPN2 exerts protective effects by ameliorating metabolic disorders and suppressing micro-inflammation via the STAT signaling pathway, which suggests PTPN2 is a potential target for the treatment of human DN [41]. The gene discussed is PTPN2; the disease is Other metabolic disease.